These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17451423)

  • 21. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial.
    Glasziou P; Alexander J; Beller E; Clarke P;
    Health Qual Life Outcomes; 2007 Apr; 5():21. PubMed ID: 17462100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
    Seufert J
    Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the diabetic patients' perceived social support on their quality-of-life.
    Göz F; Karaoz S; Goz M; Ekiz S; Cetin I
    J Clin Nurs; 2007 Jul; 16(7):1353-60. PubMed ID: 17584354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point: If it is important to prevent type 2 diabetes, it is important to consider all proven therapies within a comprehensive approach.
    Gerstein HC
    Diabetes Care; 2007 Feb; 30(2):432-4. PubMed ID: 17259525
    [No Abstract]   [Full Text] [Related]  

  • 25. Exercise for prevention of obesity and diabetes in children and adolescents.
    McCall A; Raj R
    Clin Sports Med; 2009 Jul; 28(3):393-421. PubMed ID: 19505623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study.
    Roumen C; Corpeleijn E; Feskens EJ; Mensink M; Saris WH; Blaak EE
    Diabet Med; 2008 May; 25(5):597-605. PubMed ID: 18445174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Cushman WC; Grimm RH; Cutler JA; Evans GW; Capes S; Corson MA; Sadler LS; Alderman MH; Peterson K; Bertoni A; Basile JN;
    Am J Cardiol; 2007 Jun; 99(12A):44i-55i. PubMed ID: 17599425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular prevention in patients with diabetes and prediabetes.
    Anselmino M; Gohlke H; Mellbin L; Rydén L
    Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial.
    Stiefel F; Zdrojewski C; Bel Hadj F; Boffa D; Dorogi Y; So A; Ruiz J; de Jonge P
    Psychother Psychosom; 2008; 77(4):247-56. PubMed ID: 18443391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
    Steinmetz A
    Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: a multicenter, randomized, clinical intervention trial.
    Shai I; Wainstein J; Harman-Boehm I; Raz I; Fraser D; Rudich A; Stampfer MJ
    Diabetes Care; 2007 Dec; 30(12):3011-6. PubMed ID: 17848609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotyping for early predictors of obesity and the metabolic syndrome.
    Dulloo AG; Montani JP
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S1-3. PubMed ID: 21151141
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
    Abuissa H; O'Keefe J
    Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular therapies and their role in diabetic eye disease.
    Denniston AK; Banerjee S; Gibson JM; Dodson PM
    Diabet Med; 2005 May; 22(5):665-6. PubMed ID: 15842530
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Goff DC; Gerstein HC; Ginsberg HN; Cushman WC; Margolis KL; Byington RP; Buse JB; Genuth S; Probstfield JL; Simons-Morton DG;
    Am J Cardiol; 2007 Jun; 99(12A):4i-20i. PubMed ID: 17599424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.